TranslarnaatalurenEuropean CommissionDuchenne’s disease
…ecided not to renew the conditional marketing authorisation for Translarna (ataluren) in Duchenne’s disease due to lack of efficacy after …
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Translarna ×
Translarna
This drug is selected. Its supporting articles are shown below.